Advertisement
Screener

Establishment Labs Holdings Inc. (ESTA) Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

Establishment Labs Holdings Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

Establishment Labs Holdings Inc. (ESTA) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.

Financial Statements › Notes › Leases

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-05-08

  • Establishment Labs Holdings Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00.
  • Establishment Labs Holdings Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $215.00K, a 79.00% decline year-over-year.
  • Establishment Labs Holdings Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $120.00K, a 91.16% decline year-over-year.
  • Establishment Labs Holdings Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $0.00.
  • Establishment Labs Holdings Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $335.00K, a 89.25% decline from fiscal 2024.
  • Establishment Labs Holdings Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $3.12M, a 551.67% increase from fiscal 2023.
  • Establishment Labs Holdings Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $478.00K, a 75.64% decline from fiscal 2022.
  • Establishment Labs Holdings Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $1.96M.
Period endRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month
2026-03-31$0.00
10-Q · filed 2026-05-08
$215.00K
derived: sum of 2 quarters · filed 2026-05-08
$335.00K
derived: sum of 3 quarters · filed 2026-05-08
$335.00K
derived: sum of 4 quarters · filed 2026-05-08
2025-12-31$215.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$335.00K
derived: sum of 2 quarters · filed 2026-02-27
$335.00K
derived: sum of 3 quarters · filed 2026-02-27
$335.00K
10-K · filed 2026-02-27
2025-09-30$120.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$120.00K
derived: sum of 2 quarters · filed 2025-11-07
$120.00K
10-Q · filed 2025-11-07
$1.14M
derived: sum of 4 quarters · filed 2026-05-08
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
$1.02M
derived: sum of 3 quarters · filed 2026-05-08
$2.38M
derived: sum of 4 quarters · filed 2026-05-08
2025-03-31$0.00
10-Q · filed 2026-05-08
$1.02M
derived: sum of 2 quarters · filed 2026-05-08
$2.38M
derived: sum of 3 quarters · filed 2026-05-08
$2.38M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$2.38M
derived: sum of 2 quarters · filed 2026-02-27
$2.38M
derived: sum of 3 quarters · filed 2026-02-27
$3.12M
10-K · filed 2026-02-27
2024-09-30$1.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$1.36M
derived: sum of 2 quarters · filed 2025-11-07
$2.09M
10-Q · filed 2025-11-07
$2.09M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$734.00K
10-Q · filed 2025-08-07
$734.00K
derived: sum of 3 quarters · filed 2026-02-27
$734.00K
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$734.00K
10-Q · filed 2025-05-09
$734.00K
derived: sum of 2 quarters · filed 2026-02-27
$734.00K
derived: sum of 3 quarters · filed 2026-02-27
$734.00K
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$0.00
derived: sum of 2 quarters · filed 2026-02-27
$0.00
derived: sum of 3 quarters · filed 2026-02-27
$478.00K
10-K · filed 2026-02-27
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$0.00
derived: sum of 2 quarters · filed 2024-11-12
$478.00K
10-Q · filed 2024-11-12
$611.00K
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$478.00K
10-Q · filed 2024-08-07
$611.00K
derived: sum of 3 quarters · filed 2025-02-28
$2.44M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$478.00K
10-Q · filed 2024-05-09
$611.00K
derived: sum of 2 quarters · filed 2025-02-28
$2.44M
derived: sum of 3 quarters · filed 2025-02-28
$2.44M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$133.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$1.96M
derived: sum of 2 quarters · filed 2025-02-28
$1.96M
derived: sum of 3 quarters · filed 2025-02-28
$1.96M
10-K · filed 2025-02-28
2022-09-30$1.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$1.83M
derived: sum of 2 quarters · filed 2023-11-08
$1.83M
10-Q · filed 2023-11-08
$1.83M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$0.00
10-Q · filed 2023-08-09
$0.00
derived: sum of 3 quarters · filed 2023-08-09
$0.00
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$0.00
10-Q · filed 2023-05-10
$0.00
derived: sum of 2 quarters · filed 2023-05-10
$0.00
derived: sum of 3 quarters · filed 2023-05-10
$0.00
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$0.00
derived: sum of 2 quarters · filed 2023-03-01
$0.00
derived: sum of 3 quarters · filed 2023-03-01
$0.00
10-K · filed 2023-03-01
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$0.00
10-Q · filed 2022-11-09
$0.00
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$0.00
10-Q · filed 2022-08-09
$0.00
derived: sum of 3 quarters · filed 2022-08-09
$355.00K
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$0.00
10-Q · filed 2022-05-10
$0.00
derived: sum of 2 quarters · filed 2022-05-10
$355.00K
derived: sum of 3 quarters · filed 2022-05-10
$355.00K
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$355.00K
derived: sum of 2 quarters · filed 2022-03-01
$355.00K
derived: sum of 3 quarters · filed 2022-03-01
$355.00K
10-K · filed 2022-03-01
2020-09-30$355.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$355.00K
derived: sum of 2 quarters · filed 2021-11-09
$355.00K
10-Q · filed 2021-11-09
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$0.00
10-Q · filed 2021-07-30
2020-03-31$0.00
10-Q · filed 2021-05-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85